Literature DB >> 2113079

Rapid diagnosis of Mycoplasma pneumoniae infection: clinical evaluation of a commercial probe test.

S R Kleemola1, J E Karjalainen, R K Räty.   

Abstract

A hybridization test for the diagnosis of Mycoplasma pneumoniae infection (Gen-Probe Rapid Diagnostic System) was evaluated using throat swabs and sputum samples from 160 army conscripts with acute infection of the lower respiratory tract. M. pneumoniae were cultivated from sputa, and Mycoplasma serology was done with paired sera by both complement fixation and enzyme immunoassay techniques. Comparison of the probe test results with the Mycoplasma culture and serologic results showed that the Gen-Probe test was sensitive and specific for the rapid diagnosis of acute M. pneumoniae infection of the lower respiratory tract when sputum was used: It had good sensitivity (0.95) and specificity (0.85) among patients whose serologic results were consistent with their culture results. In contrast, the probe test performed with throat swabs seemed to have only limited value.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2113079     DOI: 10.1093/infdis/162.1.70

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  18 in total

Review 1.  Molecular diagnosis of Mycoplasma pneumoniae respiratory tract infections.

Authors:  K Loens; D Ursi; H Goossens; M Ieven
Journal:  J Clin Microbiol       Date:  2003-11       Impact factor: 5.948

2.  Rapid, sensitive detection of Mycoplasma pneumoniae in simulated clinical specimens by DNA amplification.

Authors:  G E Buck; L C O'Hara; J T Summersgill
Journal:  J Clin Microbiol       Date:  1992-12       Impact factor: 5.948

Review 3.  Optimal sampling sites and methods for detection of pathogens possibly causing community-acquired lower respiratory tract infections.

Authors:  K Loens; L Van Heirstraeten; S Malhotra-Kumar; H Goossens; M Ieven
Journal:  J Clin Microbiol       Date:  2008-11-19       Impact factor: 5.948

4.  Direct identification of bacterial isolates in blood cultures by using a DNA probe.

Authors:  T E Davis; D D Fuller
Journal:  J Clin Microbiol       Date:  1991-10       Impact factor: 5.948

5.  Pneumonia in childhood: etiology and response to antimicrobial therapy.

Authors:  O Ruuskanen; H Nohynek; T Ziegler; R Capeding; H Rikalainen; P Huovinen; M Leinonen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-03       Impact factor: 3.267

6.  A multicenter, randomized study comparing the efficacy and safety of intravenous and/or oral levofloxacin versus ceftriaxone and/or cefuroxime axetil in treatment of adults with community-acquired pneumonia.

Authors:  T M File; J Segreti; L Dunbar; R Player; R Kohler; R R Williams; C Kojak; A Rubin
Journal:  Antimicrob Agents Chemother       Date:  1997-09       Impact factor: 5.191

7.  Enzyme immunoassay for detection of immunoglobulin M (IgM) and IgG antibodies to Mycoplasma pneumoniae.

Authors:  S A Uldum; J S Jensen; J Søndergård-Andersen; K Lind
Journal:  J Clin Microbiol       Date:  1992-05       Impact factor: 5.948

Review 8.  Relevance of nucleic acid amplification techniques for diagnosis of respiratory tract infections in the clinical laboratory.

Authors:  M Ieven; H Goossens
Journal:  Clin Microbiol Rev       Date:  1997-04       Impact factor: 26.132

9.  Comparison of three serological methods for diagnosing Mycoplasma pneumoniae infection.

Authors:  M Karppelin; K Hakkarainen; M Kleemola; A Miettinen
Journal:  J Clin Pathol       Date:  1993-12       Impact factor: 3.411

10.  Detection of Mycoplasma pneumoniae in clinical samples from pediatric patients by polymerase chain reaction.

Authors:  L Skakni; A Sardet; J Just; J Landman-Parker; J Costil; N Moniot-Ville; F Bricout; A Garbarg-Chenon
Journal:  J Clin Microbiol       Date:  1992-10       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.